Zelira Therapeutics: Launches first product line, RAF FIVE

Zelira Therapeutics: Launches first product line, RAF FIVE

  • Zelira Therapeutics (ZLD) launches its first product line, RAF FIVE, through its dermatology subsidiary, Ilera Derm LLC
  • The product line includes a mix of acne treatment and sunscreen, and known skin-boosting ingredients such as peptides and hyaluronic acid
  • These products are known to include skin-boosting ingredients such as glycerin, hyaluronic acid, peptides, thiotaine and niacinamide
  • RAF FIVE is now available in the US and the launch marks Zelira’s first step into the acne medication market
  • After 30 days of using the product, 92 per cent of users reported smoother skin while 90 per cent indicated blemishes cleared up more quickly
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FTC Seeks Contempt Ruling Against Payment Processor CLIQ

The FTC aims to hold CLIQ accountable for alleged non-compliance.Highlights: FTC files contempt motion against CLIQ for ignoring...

FTC Tightens Control Over Payment Processor Cliq in Contempt Ruling

Federal Trade Commission seeks legal action against Cliq for non-compliance.Highlights: FTC asks court to hold Cliq in contempt...

Portage Takes Over Management of Point72 Ventures’ Fintech Assets

Significant shift in fintech investment strategy announced by Portage.Highlights: Portage Management has taken over Point72's fintech assets.The move...

Portage Takes Over Management of Point72 Fintech Assets, Strengthening Market Position

Portage enhances its portfolio by managing Point72's fintech investments. Highlights:Portage assumes management of Point72's fintech investments. This move...